![Noriko Koizumi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Noriko Koizumi
Director/Miembro de la Junta en SEED CO.,LTD. .
Cargos activos de Noriko Koizumi
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SEED CO.,LTD. | Director/Miembro de la Junta | 24/06/2022 | - |
Independent Dir/Board Member | 24/06/2022 | - | |
Doshisha University | Corporate Officer/Principal | 01/04/2010 | - |
Graduate School of Medicine Kyoto University | Corporate Officer/Principal | 01/04/2015 | - |
ActualEyes, Inc.
![]() ActualEyes, Inc. Packaged SoftwareTechnology Services ActualEyes, Inc. is a Japanese company that conducts research and development of products such as regenerative medicine for corneal endothelial disease. The company is based in Kyotanabe, Japan. The company's mission is to deliver the desired light to patients suffering from visual impairment and to ensure and promptly implement a new treatment society. The company was founded in 2018. The CEO is Iku Sugioka. | Director Técnico/Científico/I+D | 01/05/2018 | - |
Historial de carrera de Noriko Koizumi
Formación de Noriko Koizumi.
Kyoto Prefectural University of Medicine | Undergraduate Degree |
Estadísticas
Internacional
Japón | 5 |
2 |
Operativa
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sectorial
Consumer Services | 4 |
Health Technology | 2 |
Technology Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
SEED CO.,LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
ActualEyes, Inc.
![]() ActualEyes, Inc. Packaged SoftwareTechnology Services ActualEyes, Inc. is a Japanese company that conducts research and development of products such as regenerative medicine for corneal endothelial disease. The company is based in Kyotanabe, Japan. The company's mission is to deliver the desired light to patients suffering from visual impairment and to ensure and promptly implement a new treatment society. The company was founded in 2018. The CEO is Iku Sugioka. | Technology Services |
- Bolsa de valores
- Insiders
- Noriko Koizumi
- Experiencia